S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
Log in
OTCMKTS:AITB

AIT Therapeutics Stock Forecast, Price & News

$5.89
+0.06 (+1.03 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.77
Now: $5.89
$5.99
50-Day Range
$4.65
MA: $6.03
$7.24
52-Week Range
$4.65
Now: $5.89
$4.97
Volume212,683 shs
Average Volume19,435 shs
Market Capitalization$62.32 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.31
AIT Therapeutics, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was founded in 2011 and is based in Garden City, New York.
AIT Therapeutics logo

Headlines

Insider Buys Beyond Air's Shares
June 29, 2020 |  finance.yahoo.com
AIT Therapeutics Announces $8 Million PIPE Financing
June 4, 2019 |  finance.yahoo.com
AIT Therapeutics Inc.
May 7, 2019 |  www.barrons.com
Dermira (DERM) Catches Eye: Stock Jumps 12%
March 20, 2019 |  finance.yahoo.com
AIT Therapeutics Inc
March 19, 2019 |  www.bloomberg.com
See More Headlines

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:AITB
CUSIPN/A
CIKN/A
Phone972-8684-3313
Employees10
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Net Income$-18,040,000.00

Miscellaneous

Market Cap$62.32 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.59 out of 5 stars

Medical Sector

1360th out of 1,968 stocks

Surgical & Medical Instruments Industry

126th out of 169 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$5.89
+0.06 (+1.03 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AITB News and Ratings via Email

Sign-up to receive the latest news and ratings for AITB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AIT Therapeutics (OTCMKTS:AITB) Frequently Asked Questions

What stocks does MarketBeat like better than AIT Therapeutics?

Wall Street analysts have given AIT Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AIT Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has AIT Therapeutics' stock been impacted by Coronavirus (COVID-19)?

AIT Therapeutics' stock was trading at $6.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AITB stock has decreased by 8.1% and is now trading at $5.89.
View which stocks have been most impacted by COVID-19
.

Who are AIT Therapeutics' key executives?

AIT Therapeutics' management team includes the following people:
  • Mr. Steven Adam Lisi, CEO & Chairman (Age 48)
  • Mr. Amir Avniel, Co-Founder, Pres, COO & Director (Age 45)
  • Mr. Douglas J. Beck, Chief Financial Officer (Age 58)
  • Prof. Asher Tal M.D., Sr. VP of Clinical Research & Member of Scientific Advisory Board
  • Dr. Giora Davidai M.D., Chief Medical Officer

Who are some of AIT Therapeutics' key competitors?

What other stocks do shareholders of AIT Therapeutics own?

What is AIT Therapeutics' stock symbol?

AIT Therapeutics trades on the OTCMKTS under the ticker symbol "AITB."

How do I buy shares of AIT Therapeutics?

Shares of AITB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AIT Therapeutics' stock price today?

One share of AITB stock can currently be purchased for approximately $5.89.

How much money does AIT Therapeutics make?

AIT Therapeutics has a market capitalization of $62.32 million. The company earns $-18,040,000.00 in net income (profit) each year or ($3.01) on an earnings per share basis.

How many employees does AIT Therapeutics have?

AIT Therapeutics employs 10 workers across the globe.

What is AIT Therapeutics' official website?

The official website for AIT Therapeutics is www.ait-therapeutics.com.

Where are AIT Therapeutics' headquarters?

AIT Therapeutics is headquartered at 2 ILAN RAMON SCIENCE PARK, NESS ZIONA L3, 7403635.

How can I contact AIT Therapeutics?

AIT Therapeutics' mailing address is 2 ILAN RAMON SCIENCE PARK, NESS ZIONA L3, 7403635. The company can be reached via phone at 972-8684-3313.


This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.